News|Articles|November 17, 2026

Plan Churn, Claims Format Overhaul Loom for Pharmacies in 2027

Listen
0:00 / 0:00

Key Takeaways

  • Outdated plan tables (eg, legacy PBM labels) increase rejected claims, rework, and payment delays when patients present new cards after open enrollment.
  • Medicare Part D changes for 2027 include ~50% premium increases, a $700 standard deductible, and elimination of $0 stand-alone plans, driving substantial plan switching.
SHOW MORE

Owners believe clean plan-to-patient matching before January 1 is one of the simplest ways to protect cash flow in 2027.

When patients start arriving with new insurance cards at the start of 2027, pharmacies with outdated plan records, such as entries still labeled Medco or Advance Rx years after those PBMs were acquired, will pay for it in rejected claims, delayed payments, and long calls with insurers, according to a recent webinar conducted by a group of pharmacist-owners.1

“If you’re billing Part B and the person is on [Medicare] Advantage, you’re going to get a rejection, and then you’re going to have to go reprocess that claim against the Advantage plan,” said Benjamin Jolley, PharmD, practicing pharmacist at Jolley’s Compounding Pharmacy and co-founder of Apex Pharmacy Consulting and PharmacyAI. “I have to go bill it, and now I get paid 2 weeks later. Instead, bill it correctly on the first try.”

Jolley and his colleagues gathered virtually to provide their pharmacy-owner-focused audience with a practical roadmap for driving their businesses at the start of 2027. He was joined by Joe Williams, PharmD, Apex and PharmacyAI co-founder, and Neal Smoller, PharmD, the third co-founder of PharmacyAI and owner of multiple additional entrepreneurial endeavors in pharmacy, in a webinar designed to get independent pharmacies ahead strategically and financially before the new year.1

Titled “PharmacyAI Lab: Get ahead of January 1, and meet PharmacyAI,” the webinar was conducted virtually on November 12, 2026.

READ MORE: Future IRA Drug Negotiations Expected to Compound Pharmacy Burden

Premium Surges and Plan Churn Create Open Enrollment Volatility

The motivation for independent pharmacies to audit patient records early is driven by unprecedented upheaval across public and commercial prescription drug coverage. In the Medicare Part D market, the estimated average monthly premium for stand-alone prescription drug plans is projected to jump 50%, moving from $34 in 2026 to $51 in 2027, if enrollees remain in their current coverage.2

Policy analysts at KFF report that 76% of stand-alone plan enrollees without low-income subsidies, representing roughly 10.4 million seniors, will face higher monthly payments unless they switch plans during open enrollment. This financial burden is heightened by the complete elimination of zero-dollar monthly premium stand-alone plans for 2027, forcing 4.1 million beneficiaries into paid plans. The surge follows the conclusion of the federal Part D Premium Stabilization Demonstration, which previously capped monthly premium increases at $50. Furthermore, the standard Part D deductible is set to rise to $700, with 99.8% of stand-alone plan enrollees facing a deductible.2

Simultaneously, massive coverage turnover is expected within Affordable Care Act (ACA) Marketplaces. Benchmark silver premiums on the ACA Marketplaces are increasing by an average of 13% for 2027, compounding a 26% increase from the previous year and resulting in a 2-year cumulative rate hike of 42%.3

Rising medical costs and the expiration of enhanced federal tax credits are driving major insurer exits, such as Cigna withdrawing its individual market coverage across all 11 states where it operates. Projections from the Congressional Budget Office suggest that overall ACA Marketplace enrollment could drop from a peak of 22.4 million in 2025 down to 13.1 million in 2027.

As millions of consumers switch or lose coverage, pharmacies will experience a surge of patients presenting unfamiliar insurance details at the counter.1

Federal Mandates Enforce Technical Claims Transition to Version F6

Adding to coverage plan churn, independent pharmacies face a significant structural modification to how electronic prescription claims are processed nationwide. Under a final rule issued by the Department of Health and Human Services (HHS), covered entities must transition to updated HIPAA retail pharmacy transaction standards, specifically National Council for Prescription Drug Programs (NCPDP) Version F6 and Version 15.4

The regulation establishes an 8-month voluntary transition period starting on August 14, 2027, followed by a mandatory compliance deadline of April 14, 2028. This regulatory update requires pharmacy management systems and prescription drug plans to transition from standard 6-digit Bank Identification Numbers to 8-digit Issuer Identification Numbers while updating electronic messaging formats.1,4

During the webinar, Jolley highlighted that technical format changes historically cause severe operational hurdles for independent pharmacies if systems are unprepared. Reflecting on the prior industry-wide claims format transition in 2008 and 2009, Jolley explained that uncoordinated technical updates can lead to widespread claim rejections, among other potential bottlenecks.1

Navigating both widespread coverage churn and an industry-wide transaction format update creates a double burden for pharmacy staff who rely on outdated plan tables.

Operational Audit and Clean Patient Records Protect Pharmacy Cash Flow

The financial stakes of misaligned plan records are particularly evident when handling preventive care services and clinical immunizations.

Direct billing guidelines from the Centers for Medicare and Medicaid Services (CMS) require providers to submit COVID-19 vaccine administration claims for Medicare Advantage enrollees directly to their specific Medicare Advantage Plan rather than Original Medicare Part B.5

Beneficiaries are entitled to receive these vaccines with zero out-of-pocket costs, meaning pharmacies cannot bill deductibles or copayments to the patient. If a pharmacy mistakenly bills Original Medicare Part B for a patient who shifted into a Medicare Advantage plan during open enrollment, the claim is rejected immediately, creating delayed reimbursement and extra administrative work for staff.1,5

To prevent these billing disruptions and safeguard working capital, webinar speakers urged pharmacy owners to clean their plan databases before the new year arrives. Automating plan-to-patient matching across the 188,000 Medicare plan and county combinations ensures that patient profiles reflect accurate active coverage prior to January 1.1

Clean plan mapping allows pharmacy technicians to explain deductible tiers and expected cost-sharing clearly to patients, avoiding counter confusion and long phone calls with plan help desks. Investing time in plan table maintenance before January 1 enables independent pharmacies to protect their cash flow, reduce administrative overhead, and maintain high standards of patient care throughout 2027.

READ MORE: Pharmacies Face Persistent MFP Cash Crunch Amid PBM, 340B Shifts

REFERENCES
1. Jolley B, Williams J, Smoller N, et al. Get ahead of January 1, and meet PharmacyAI. PharmacyAI. Presented virtually on November 12, 2026. Accessed November 16, 2026. https://www.pharmacyai.com/hubfs/PharmacyAI-Lab-1-replay.mp4
2. Cubanski J, Freed M, Ochieng N. Medicare Part D premiums and cost sharing in 2027. KFF. October 30, 2026. Accessed November 16, 2026. https://www.kff.org/medicare/medicare-part-d-premiums-and-cost-sharing-in-2027/
3. McGough M, Wallace R, Lo J, et al. 9 things to watch for the 2027 ACA open enrollment period. November 6, 2026. Accessed November 16, 2026. https://www.kff.org/affordable-care-act/9-things-to-watch-for-the-2027-aca-open-enrollment-period/
4. Administrative simplification: modifications of Health Insurance Portability and Accountability Act of 1996 (HIPAA), National Council for Prescription Drug Programs (NCPDP) retail pharmacy standards; and modification of the Medicaid Pharmacy Subrogation Standard; updates to compliance and other related dates. US Department of Health and Human Services. August 21, 2025. Accessed November 16, 2026. https://public-inspection.federalregister.gov/2025-15958.pdf
5. Medicare billing for COVID-19 vaccine shot administration. US Centers for Medicare & Medicaid Services. March 13, 2026. Accessed November 16, 2026. https://www.cms.gov/medicare/payment/covid-19-vaccine-toolkit/medicare-billing-covid-19-vaccine-shot-administration

Related to this article